DTMGX
Price
$42.48
Change
-$0.32 (-0.75%)
Updated
Sep 20 closing price
RGACX
Price
$74.37
Change
-$0.14 (-0.19%)
Updated
Sep 20 closing price
Ad is loading...

DTMGX vs RGACX

Header iconDTMGX vs RGACX Comparison
Open Charts DTMGX vs RGACXBanner chart's image
BNY Mellon Tax Managed Growth A
Price$42.48
Change-$0.32 (-0.75%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R3
Price$74.37
Change-$0.14 (-0.19%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
DTMGX vs RGACX Comparison Chart
Loading...
VS
DTMGX vs. RGACX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTMGX is a Buy and RGACX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 290B vs. DTMGX (146M). DTMGX pays higher dividends than RGACX: DTMGX (0.35) vs RGACX (0.25). DTMGX was incepted earlier than RGACX: DTMGX (27 years) vs RGACX (22 years). RGACX is a more actively managed with annual turnover of: 31.00 vs. DTMGX (1.73). RGACX has a lower initial minimum investment than DTMGX: RGACX (250) vs DTMGX (1000). RGACX annual gain was more profitable for investors over the last year : 29.53 vs. DTMGX (15.96). RGACX return over 5 years is better than : 51.78 vs. DTMGX (43.60).
DTMGXRGACXDTMGX / RGACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years22 years-
Gain YTD13.88421.44065%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets146M290B0%
Annual Yield % from dividends0.350.25136%
Returns for 1 year15.9629.5354%
Returns for 3 years0.27-0.49-56%
Returns for 5 years43.6051.7884%
Returns for 10 years64.3965.2099%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COHR87.020.96
+1.12%
Coherent Corp
FOXF43.03-0.34
-0.78%
Fox Factory Holding Corp
GNSS3.46-0.03
-0.86%
Genasys
ENSC0.32-0.01
-2.45%
Ensysce Biosciences
IIIV21.99-0.68
-3.00%
i3 Verticals